Grants and Funding
NIH Human Embryonic Stem Cell Registry
Research Using This Line is Eligible for NIH Funding

Detailed information for selected cell line:

Cell Line: NYUES11; abnormal karyotype
NIH Registration Number: 0236
NIH Approval Number: NIHhESC-13-0236
Available for Distribution: Yes
Provider Restrictions: 1. A new destination site (e.g., university, research institute) where these hESCs would be shipped may need to be added to the study protocol and approved by the IRB of New York University School of Medicine;

2. These hESCs or their derivatives cannot be used for transplantation into humans.

NIH Restrictions: (No Additional Restrictions)
Additional Information: The cell line carries trisomy 14 and is male. Further information about the characteristics of the hESCs is available at chris.hansis@med.nyu.edu or chrhansis@aol.com.

Submitting Organization: New York University School of Medicine
Provider Name: Christoph Hansis, MD, PhD
Provider Phone:  
Provider Email: chris.hansis@med.nyu.edu;chrhansis@aol.com
Provider URL:  
Approval Date: 12/23/2013


View All Lines Eligible for Use

Go to NIH Form 2890 Login Page

Go to NIH Stem Cell Information Page


   
Related Resources

    NIH Form 2890:

  • Login Page
    (Authorization Required)
    Contact Us:

  • Email questions to:
    hescregistry@mail.nih.gov

  • (Emails that are offensive or unrelated to stem cells will be deleted.)
 

This page last updated on July 13, 2011
Content Manager: stemcell@mail.nih.gov 
Technical Issues: E-mail OER Webmaster